International Clinical Trial: Safety and Efficacy of BlueDoc Digital Therapeutic for Older Adults with Depressive Disorder

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (KCT0012628) titled 'Safety and Efficacy of BlueDoc Digital Therapeutic for Older Adults with Depressive Disorder' on Sept. 15.

Study Type: Interventional Study

Study Design: Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT

Primary Sponsor: Korea University

Condition:

Mental and behavioural disorders

Intervention: Medical Device, Behavioral : Participants in the experimental group use BlueDoc, a behavioral activation-based digital therapeutic, for 8 weeks beginning after the baseline assessment. BlueDoc is a software medical device delivered through a smartphone or tablet and pr...